Milestone Pharmaceuticals Inc.
Pagina dedicata companiei Milestone Pharmaceuticals Inc. listata cu simbolul US.MIST
Descriere companie[edit | ]
Milestone Pharmaceuticals Inc. (https://milestonepharma.com/) is a biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Milestone’s lead product candidate is etripamil. The etripamil is a novel, potent and short-acting calcium channel blocker that has been designed rapid-onset nasal spray, which is self-administered by patients. The Company is developing etripamil to treat paroxysmal supraventricular tachycardia (PSVT), atrial fibrillation (AF) and rapid ventricular rate, and other cardiovascular indications.
Grafic actiuni companie[edit | ]